XML 39 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Earnings Per Share (Tables)
 9 Months Ended
Sep. 30, 2024
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
The following table presents the basic and diluted earnings per share computations for the three and nine months ended September 30, 2024 and 2023:
Three Months Ended September 30,Nine Months Ended September 30,
(in thousands, except per share data)2024202320242023
Net income$9,054 $17,957 $30,381 $63,560 
Participating basic earnings (a)(59)(41)(153)(109)
Basic earnings attributable to common stockholders8,995 17,916 30,228 63,451 
Reallocation of participating earnings— — — — 
Diluted earnings attributable to common stockholders$8,995 $17,916 $30,228 $63,451 
Weighted average common shares outstanding:
Weighted average common shares outstanding – basic130,204 134,396 130,182 133,426 
Dilutive performance stock units29 11 27 8 
Dilutive stock options9 14 10 6 
Weighted average common shares outstanding – diluted130,242 134,421 130,219 133,440 
Net income per common share:
Basic$0.07 $0.13 $0.23 $0.48 
Diluted$0.07 $0.13 $0.23 $0.48 
(a) Unvested restricted stock awards represent participating securities because they participate in nonforfeitable dividends or distributions with the common equity holders of the Company. Participating earnings represent the distributed and undistributed earnings of the Company attributable to the participating securities. Unvested restricted stock awards do not participate in undistributed net losses as they are not contractually obligated to do so.
Schedule of Diluted Earnings Per Share, Diluted Securities
The following table is a summary of the PSUs and stock options, which were not included in the computation of diluted earnings per share, as inclusion of these items would be antidilutive.
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Number of antidilutive common shares:
Antidilutive performance stock units74,096 21,007 49,588 17,689 
Antidilutive stock options517,818 378,067 485,608 271,788 
Total antidilutive common shares591,914 399,074 535,196 289,477